Enliven Therapeutics (ELVN) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
ELVN is expected to report earnings to rise 7.42% to -51 cents per share on March 13
Q4'24
Est.
$-0.52
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.14
Q1'24
Est.
$-0.54
Q1'23
Missed
by $0.17
The last earnings report on November 13 showed earnings per share of -47 cents, beating the estimate of -50 cents. With 105.17K shares outstanding, the current market capitalization sits at 1.19B.